Skip to content

Clinical research on the application of Fire Dragon Cupping combined moxibustion in improving the success rate of nasointestinal tube placement in critically ill patients

Clinical research on the application of Fire Dragon Cupping combined moxibustion in improving the success rate of nasointestinal tube placement in critically ill patients

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600117287
Enrollment
Unknown
Registered
2026-01-22
Start date
2026-01-22
Completion date
Unknown
Last updated
2026-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastrointestinal dysfunction

Interventions

Experimental group:Twenty minutes before the catheter insertion, a comprehensive moxibustion treatment using fire dragon needles was administered to the patient. During the catheter insertion process,
Control group:10 to 15 minutes before the catheter insertion, administer 10 mg of metoclopramide intravenously.

Sponsors

Hangzhou Traditional Chinese Medicine Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: (1)Admitted to the ICU; (2) Age >=18 years old, gender not limited; (3) Those who need to have a nasojejunal tube inserted for enteral nutrition treatment; (4) The estimated length of stay in the ICU and the time required for nutritional support are greater than 72 hours. (5) Voluntarily participate in this study and sign the informed consent form.

Exclusion criteria

Exclusion criteria: (1) Those who have undergone percutaneous gastrostomy or jejunostomy; (2) Those with a history of esophageal reconstruction or subtotal gastrectomy in the past; (3) Those with gastric fundus esophageal varices, malignant tumors of the stomach, esophageal stenosis, and active upper gastrointestinal bleeding; (4) Those with maxillofacial and skull base injuries, and those with a clear tendency of intracranial rebleeding; (5) Those with severe coagulation dysfunction; (6) Those with severe arrhythmia; (7) People allergic to metoclopramide; (8) Patients allergic to mugwort smoke.

Design outcomes

Secondary

MeasureTime frame
Catheterization duration;CPOT score;Vital signs before and after catheterization;Incidence of catheterization complications;The incidence of adverse events within 7 days after catheterization;

Primary

MeasureTime frame
Success rate of one-time catheterization;Success rate of catheterization;

Countries

China

Contacts

Public ContactLai Meihong

Hangzhou Traditional Chinese Medicine Hospital

laimeihong557@sohu.com+86 187 5806 5851

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026